TrialClinical cancer research : an official journal of the American Association for Cancer Research2025

A Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor-Positive Breast Cancer: The BRACELET-01/PrE0113 Study.

Amy S Clark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.